Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index

Table 1.: Characteristics of the study participants.

Characteristics	Patients (n = 37)
M/F ratio Mean age (yrs) BMI (kg.m-2) Smoking status Daily smokers Pack-years smoked Ex-smokers Dyspnea (MRC score) Sputum production Mean FVC value (% pred.) Mean FEV1 value (% pred.) Chronic colonisation Pseudomonas aeruginosa Other microorganisms Number of lobes affected Exacerbation in previous year Hospitalization in previous year Chronic treatment in previous year Systemic antibiotics Macrolides Oral corticosteroids	0.8 63.4 ± 8.1 24.3 ± 3.7 14 (37.8%) 12.8 ± 5.7 5 (13.5%) 1.83 ± 0.63 29 (78.4%) 73.8 ± 11.4 57.6 ± 8.7 3 (8.1%) 6 (16.3%) 2. 25 ± 0.78 2.12 ± 0.54 1.14 ± 0.37 8 (21.6%) 3 (8.1%) 6 (16.3%)

Characteristics

Patients (n = 37)

M/F ratio
Mean age (yrs)
BMI (kg.m-2)

Smoking status
Daily smokers
Pack-years smoked
Ex-smokers

Dyspnea (MRC score)
Sputum production

Mean FVC value (% pred.)
Mean FEV1 value (% pred.)

Chronic colonisation
Pseudomonas aeruginosa
Other microorganisms

Number of lobes affected

Exacerbation in previous year
Hospitalization in previous year

Chronic treatment in previous year
Systemic antibiotics
Macrolides
Oral corticosteroids

0.8
63.4 ± 8.1
24.3 ± 3.7

14 (37.8%)
12.8 ± 5.7
5 (13.5%)

1.83 ± 0.63
29 (78.4%)

73.8 ± 11.4
57.6 ± 8.7

3 (8.1%)
6 (16.3%)

2. 25 ± 0.78

2.12 ± 0.54
1.14 ± 0.37

8 (21.6%)
3 (8.1%)
6 (16.3%)

Numerical data are expressed as a mean value with standard deviation; the frequencies as a number and percentage of patients with certain variableM: male; F: female; yrs: years; BMI: body mass index; kg: kilogram; m: meter; MRC: Medical Research Council; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; % pred.: % of predicted value.